© Oxford University Press, 2004.
Review |
Exercise as a Time-conditioning Effector in Chronic Disease: a Complementary Treatment Strategy
Laboratory of Metabolism, Department of Histology and Embryology, Institute of Biomedical Sciences, University of São Paulo, Brazil
Exercise has been widely believed to be a preventive and therapeutic aid in the treatment of various pathophysiological conditions such as cardiovascular disease and cancer. A common problem associated with such pathologies is cachexia, characterized by progressive weight loss and depletion of lean and fat body mass, and is linked to poor prognosis. As this syndrome comprises changes in many physiological systems, it is tempting to assume that the modulation of the psychoneuroimmunoendocrine axis could attenuate or even prevent cachexia progression in cancer patients. Cancer cachexia is characterized by a disruption in the rhythmic secretion of melatonin, an important time-conditioning effector. This hormone, secreted by the pineal gland, transmits circadian and seasonal information to all organs and cells of the body, synchronizing the organism with the photoperiod. Considering that exercise modulates the immune response through at least two different mechanismsmetabolic and neuroendocrinewe propose that the adoption of a regular exercise program as a complementary strategy in the treatment of cancer patients, with the exercise bouts regularly performed at the same time of the day, will ameliorate cachexia symptoms and increase survival and quality of life.
Keywords: exercise – time-conditioning effector – neuroimmunoendocrine system – glutamine – cachexia
For reprints and all correspondence: Luis F.B.P. Costa Rosa, Lab. De Metabolismo, Instituto de Ciencias Biomedicas, Av. Prof. Lineu Prestes 1524, sala 302, Cidade Universitária, São Paulo 05508-900, Brazil. E-mail: ggrosa{at}icb.usp.br
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Liu, Z. Jia, L. Dong, R. Wang, and G. Qiu A Randomized Pilot Study of Atractylenolide I on Gastric Cancer Cachexia Patients Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 337 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. N. Bacurau, M. A. Belmonte, F. Navarro, M. R. Moraes, F. L. Pontes Jr., J. L. Pesquero, R. C. Araujo, and R. F. P. Bacurau Effect of a High-Intensity Exercise Training on the Metabolism and Function of Macrophages and Lymphocytes of Walker 256 Tumor-Bearing Rats Exp Biol Med, November 1, 2007; 232(10): 1289 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hidaka, Y. Okamoto, S. Uchiyama, A. Nakatsuma, K. Hashimoto, S. T. Ohnishi, and M. Yamaguchi Royal Jelly Prevents Osteoporosis in Rats: Beneficial Effects in Ovariectomy Model and in Bone Tissue Culture Model Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 339 - 348. [Abstract] [Full Text] [PDF] |
||||

